Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 11, 2020

SELL
$42.0 - $48.25 $217,896 - $250,321
-5,188 Closed
0 $0
Q3 2019

Nov 05, 2019

SELL
$40.46 - $43.52 $82,659 - $88,911
-2,043 Reduced 28.25%
5,188 $221,000
Q2 2019

Aug 19, 2019

SELL
$39.4 - $42.7 $532,372 - $576,962
-13,512 Reduced 65.14%
7,231 $289,000
Q1 2019

May 08, 2019

BUY
$38.57 - $42.69 $3,239 - $3,585
84 Added 0.41%
20,743 $867,000
Q4 2018

Mar 01, 2019

SELL
$37.8 - $42.69 $47,628 - $53,789
-1,260 Reduced 5.75%
20,659 $789,000
Q3 2018

Nov 19, 2018

BUY
$39.75 - $42.69 $871,280 - $935,722
21,919 New
21,919 $880,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.2B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Griffin Asset Management, Inc. Portfolio

Follow Griffin Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Griffin Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Griffin Asset Management, Inc. with notifications on news.